Şunu aradınız:: enhance (Yunanca - İngilizce)

[enhance] n=2378
[enhance] n=2378 19 (0.8%) 18 (0.8%) 11 (0.5%) 4 (0.2%)

3. 3% έναντι 2. 0% enhance:
3.3% vs 2.0%; enhance:

Δροτρεκογίνη άλφα (ενεργοποιημένη) [enhance] n=2378
drotrecogin alfa (activated) [enhance] n=2378

Στη μελέτη enhance, το xigris χορηγήθηκε σε περισσότερους από 2. 000 ασθενείς.
in the enhance study, over 2,000 patients received xigris.

to enhance the recognition of social economy enterprises and organizations and increase the number of partnerships with them
to enhance the recognition of social economy enterprises and organisations and increase the number of partnerships with them

to enhance knowledge relating to promoting social economy enterprises and organizations and reinforcing african social economy networks
to enhance knowledge relating to promoting social economy enterprises and organisations and reinforcing african social economy networks

Η συχνότητα εμφάνισης των σοβαρών αιμορραγικών συμβαμάτων, στις κλινικές μελέτες prowess και enhance, αναφέρεται κατωτέρω.
the incidence of serious bleeding events in the prowess and enhance studies is provided below.

enhance the dialogue on energy policy in the context of the preparation of an israeli energy master plan (e.g.
enhance the dialogue on energy policy in the context of the preparation of an israeli energy master plan (e.g. workshops)

in order to cooperate in data-related research and innovation, enhance community building around data, a contractual arrangement on the ppp has been signed on october 2014.
in order to cooperate in data-related research and innovation, enhance community building around data, a contractual arrangement on the ppp has been signed on october 2014.

this project’s aim is to reverse the decline and enhance the breeding populations and range of the lesser spotted eagle (aquila pomarina) in the bialowieza and knyszynska forests by 2015.
this project’s aim is to reverse the decline and enhance the breeding populations and range of the lesser spotted eagle ( aquila pomarina ) in the bialowieza and knyszynska forests by 2015.

Στη κλινική μελέτη, ανοικτού σχεδιασμού enhance, η συχνότητα εμφάνισης σοβαρών αιμορραγικών επεισοδίων, κατά τη διάρκεια των 28-ημερών της μελέτης, ήταν 6,5 % και η συχνότητα εμφάνισης αιμορραγίας στο ΚΝΣ, κατά τη διάρκεια των 28-ημερών της μελέτης, ήταν 1,5 %.
in the open-label enhance study, the incidence of serious bleeding events during the 28-day study period was 6.5%, and the incidence of cns bleeds during the 28-day study period was 1.5%.